Merck Named in SEC, DOJ Probes Over Vioxx (Reuters) Reuters - Merck   Co. Inc.  said on\Monday it had received a subpoena from the U.S. Justice\Department and that the Securities and Exchange Commission has\started an informal inquiry concerning its recalled pain\reliever Vioxx.